Overview
My research interests focus on issues affecting the translation of genomics to clinical practice. Specifically, I have a strong interest in education, with each of my research projects involving some component of professional, public or patient education, including development of educational materials about genomic research in general, pharmacogenetic testing, and communicating genetic test results, in addition to undergraduate teaching in genetics/genomics, ethics, and policy.
Areas of expertise: Bioethics and Health Behavior
Areas of expertise: Bioethics and Health Behavior
Current Appointments & Affiliations
Professor in Medicine
·
2023 - Present
Medicine, General Internal Medicine,
Medicine
Associate Research Professor in the Sanford School of Public Policy
·
2014 - Present
Sanford School of Public Policy
Associate Research Professor of Biology
·
2018 - Present
Biology,
Trinity College of Arts & Sciences
Affiliate of the Duke Initiative for Science & Society
·
2014 - Present
Duke Science & Society,
University Initiatives & Academic Support Units
Executive Team Member of Duke Center for Applied Genomics and Precision Medicine
·
2014 - Present
The Precision Medicine Program,
Medicine
Recent Publications
Characterization of Research Support of Genome Editing Technologies and Transition to Clinical Trials.
Journal Article CRISPR J · October 2024 Genome editing technologies have become widely used research tools. To assess the rate of growth with respect to federal funding of gene editing projects, we analyzed publicly available data retrieved from the NIH RePORTER and Clinicaltrials.gov databases. ... Full text Link to item CitePharmacogenetic testing in primary care could bolster depression treatment: A value proposition.
Journal Article Clin Transl Sci · June 2024 Pharmacogenetic testing could reduce the time to identify a safe and effective medication for depression; however, it is underutilized in practice. Major depression constitutes the most common mental disorder in the US, and while antidepressant therapy can ... Full text Link to item CiteAssessment of the current status of real-world pharmacogenomic testing: informed consent, patient education, and related practices.
Journal Article Front Pharmacol · 2024 Introduction: The practice of informed consent (IC) for pharmacogenomic testing in clinical settings varies, and there is currently no consensus on which elements of IC to provide to patients. This study aims to assess current IC practices for pharmacogeno ... Full text Link to item CiteRecent Grants
NHGRI Research Training and Career Development Annual Meeting
ConferencePrincipal Investigator · Awarded by National Human Genome Research Institute · 2021 - 2026Summer Scholars in Genome Sciences & Medicine
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2026Implementing Pharmacogenomics in Diverse Health Care Systems
ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2024View All Grants
Education, Training & Certifications
University of Maryland, Baltimore ·
1999
Ph.D.